Rodolfo Caminiti

MD | Interventional Cardiology Fellow, GOM Reggio Calabria | Cardiology Resident, University Hospital of Messina

[Davide Capodanno @DFCapodanno]

The 2023 ESC guidelines for the management of acute coronary syndromes are online, for the first time reporting in the same document the recommendations for STEMI, NSTE-ACS and unstable angina. #ESCCongress https://t.co/LouGlXNuZB

[Rodolfo Caminiti @RodolfoCaminiti]

#Shockwave #IVL therapy is the best choice for interventional cardiologist in the treatment underexpanded stents. This is confirmed by our study just published in The American Journal of Cardiology.
@ShockwaveIVL @micari_antonio @giampieroviz #cardiology #interventionalcardiology

[EuroIntervention @EuroInterventio]

This study demonstrated a continuous, inverse relationship between the QFR value of a vessel and its subsequent risk for MI, and PCI, compared to medical therapy, reduced this risk beginning at a QFR value of 0.64. https://t.co/bU3gbcobG4

[Giampiero Vizzari @giampieroviz]

Take Home Messages from the last (but not least) Live in the Box from Padua @ #JIMGISE2023 @sicigise
@G_Tarantini01 introduced us a dedicated stepwise approach for THV in THV
👉Several aspects to be taken into account when planning ViV.
👉Post-procedural CT scan to be considered

[SIC Società Italiana di Cardiologia @SIC_CARDIOLOGIA]

CARDIOPENTATHLON della SIC: competizione tra Scuole di Specializzazione di 39 Università italiane: I giovani bravi della SIC a confronto. Le nuove generazioni colte e appassionate. Ci vediamo a Dicembre al Congresso Nazionale per il superquiz !

[Davide Capodanno @DFCapodanno]

Intravascular lithotripsy interferes with the fluoropolymer of DES (e.g., small tears, micro-cracks and detachments of polymer flakes) but the overall integrity of the coating remains preserved. These changes also occur after high-pressure dilatation. https://t.co/UADnYw5s9o

[Davide Capodanno @DFCapodanno]

In patients undergoing PCI for non-complex lesions in the ONE-MONTH DAPT trial, the benefits of 1-mo DAPT followed by aspirin monotherapy versus 6-12 mo DAPT on a composite of ischaemic and bleeding outcomes were observed in stable CAD but not in ACS.
https://t.co/chvfXwAgUW

[EHJ Editor-in-Chief @ehj_ed]

Which is the intermediate-term impact of mild to moderate SARS-CoV-2 infection on organ-specific function? Check it in EHJ!
https://t.co/1QbLLBiEUO

#CVD #SARS #COVID19 #cardiotwitter @escardio @ESC_Journals

[Rodolfo Caminiti @RodolfoCaminiti]

Tolerance of sustained VF during LV assist device support with IMPELLA CP®️
https://t.co/nOKK7u0Sve
#impella #impellacp #cardiacsupport #cardiotwitter #interventionalcardiology
@CreaPasquale @giampieroviz @Abiomed @CRMjournal

[EHJ Editor-in-Chief @ehj_ed]

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. Read more in #EHJ
#CardioTwitter #atherosclerosis @ESC_Journals @escardio
https://t.co/fT9hBx72Bi

https://t.co/sNI0WTOxiW

[Davide Capodanno @DFCapodanno]

This mechanical thrombectomy device, called NeVa, has been designed to improve the incorporation and removal of large, organised thrombi. Here are the results of its first-in-human prospective study in patients with acute coronary syndromes. https://t.co/pGzvMwFE2t

[Rodolfo Caminiti @RodolfoCaminiti]

Our work on "THE ROLE OF IMPELLA CP IN THE MANAGEMENT OF MALIGNANT ARRHYTHMIAS: A CASE OF ASYMPTOMATIC VENTRICULAR FIBRILLATION" awarded as best abstract at the 82nd National Congress of the @SIC_CARDIOLOGIA. #SIC #SIC2021 #icot @giampieroviz @CreaPasquale @micari_antonio